BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4201115)

  • 1. Demonstration of the production of the long acting thyroid stimulator (LATS) by peripheral lymphocytes cultured in vitro.
    Wall JR; Good BF; Forbes IJ; Hetzel BS
    Clin Exp Immunol; 1973 Aug; 14(4):555-61. PubMed ID: 4201115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graves--Basedow disease and immunity.
    Thomas M; Perrault M
    Mater Med Pol; 1975; 7(1):31-4. PubMed ID: 1079897
    [No Abstract]   [Full Text] [Related]  

  • 3. [An antibody called LATS].
    Letonturier P; Tourneur R
    Nouv Presse Med; 1975 Jan; 4(3):177-9. PubMed ID: 1079340
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy.
    Földes J; Takó J; Bános C; Gesztesi E
    Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of iodinization on some properties of LATS and antithyroid antibodies].
    Romaldini JH; Pinchera A; Fenzi GF; Grasso L; Raccis E; Mariotti S; Baschieri L
    Folia Endocrinol; 1974 Feb; 27(1):110-6. PubMed ID: 4549507
    [No Abstract]   [Full Text] [Related]  

  • 6. LATS production by lymphocyte culture in patients with Graves' disease.
    Miyai K; Fukuchi M; Kumahara Y; Abe H
    J Clin Endocrinol Metab; 1967 Jun; 27(6):855-60. PubMed ID: 4165125
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS).
    Chopra IJ; Solomon DH; Limberg NP
    J Clin Endocrinol Metab; 1970 Oct; 31(4):382-90. PubMed ID: 5468701
    [No Abstract]   [Full Text] [Related]  

  • 8. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
    Knight A; Adams DD
    Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of immunologic reaction of long acting thyroid stimulator (LATS) to thyroid components, and the demonstration of a plasma inhibitor LATS.
    Burke G
    J Lab Clin Med; 1967 May; 69(5):713-27. PubMed ID: 4960804
    [No Abstract]   [Full Text] [Related]  

  • 10. [LATS and other antibodies against the TSH receptor].
    Rodríguez Zapata MM
    Med Clin (Barc); 1983 Feb; 80(4):177-81. PubMed ID: 6134881
    [No Abstract]   [Full Text] [Related]  

  • 11. Demonstration of the production of human thyroid-stimulating immunoglobulins (HTSI) by Graves' lymphocytes cultured in vitro with phytohaemagglutinin (PHA).
    Knox AJ; von Westarp C; Row VV; Volpé R
    Metabolism; 1976 Nov; 25(11):1217-23. PubMed ID: 185485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Absent biological demonstration of "long-acting thyroid stimulator" (LATS) in endemic euthyroid iodine deficiency goiters].
    Stelzer M; Mertz DP
    Munch Med Wochenschr; 1969 Jun; 111(23):1306-9. PubMed ID: 5820134
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recent findings on TSH, LATS and TSI].
    Yamashita K; Kugai N
    Nihon Rinsho; 1981 Sep; 39(9):2949-53. PubMed ID: 6121923
    [No Abstract]   [Full Text] [Related]  

  • 14. Isoelectric focusing of long-acting thyroid stimulator immunoglobulin G.
    Lonergan C; Babiarz D; Burke G
    J Clin Endocrinol Metab; 1973 Mar; 36(3):439-44. PubMed ID: 4631063
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of long-acting thyroid stimulator. Reflections on the 1st series of results].
    Tourneur R; Letonturier P; Sénécal P
    Minerva Med; 1974 Mar; 65(19):995-8. PubMed ID: 4406464
    [No Abstract]   [Full Text] [Related]  

  • 16. [Standardization of the radiobiological method for determination of long-acting thyroid stimulator (LATS) in human serum].
    Muramoto E; Nicolau W; Ikeda E; de Assis LM; Pieroni RR
    AMB Rev Assoc Med Bras; 1972 Oct; 18(10):379-88. PubMed ID: 4539360
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relation between Basedow's disease and Hashimoto thyroiditis].
    Földes J; Takó J; Bános C; Gesztesi E; Juhász J
    Endokrinologie; 1971 Apr; 57(3):329-37. PubMed ID: 5108742
    [No Abstract]   [Full Text] [Related]  

  • 18. Concentration of long-acting thyroid stimulator (LATS) by subfractionation of gamma G globulin from Graves' disease serum.
    Miyai K; Werner SC
    J Clin Endocrinol Metab; 1966 May; 26(5):504-12. PubMed ID: 5952570
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
    Bech K
    Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
    [No Abstract]   [Full Text] [Related]  

  • 20. LATS and Graves' disease.
    Soloman DH; Chopra IJ
    Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.